Baillie Gifford & Co’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-360,650
| Closed | -$2.17M | – | 203 |
|
|
2015
Q4 | $2.17M | Hold |
360,650
| – | – | ﹤0.01% | 172 |
|
|
2015
Q3 | $2.82M | Hold |
360,650
| – | – | 0.01% | 179 |
|
|
2015
Q2 | $2.21M | Hold |
360,650
| – | – | ﹤0.01% | 181 |
|
|
2015
Q1 | $2.9M | Hold |
360,650
| – | – | 0.01% | 180 |
|
|
2014
Q4 | $1.83M | Hold |
360,650
| – | – | ﹤0.01% | 184 |
|
|
2014
Q3 | $1.87M | Hold |
360,650
| – | – | ﹤0.01% | 188 |
|
|
2014
Q2 | $2.8M | Hold |
360,650
| – | – | 0.01% | 184 |
|
|
2014
Q1 | $2.52M | Buy |
360,650
+256,650
| +247% | +$1.79M | 0.01% | 184 |
|
|
2013
Q4 | $623K | Buy |
104,000
+56,145
| +117% | +$336K | ﹤0.01% | 190 |
|
|
2013
Q3 | $373K | Buy |
47,855
+25,000
| +109% | +$195K | ﹤0.01% | 182 |
|
|
2013
Q2 | $87K | Buy |
+22,855
| New | +$87K | ﹤0.01% | 178 |
|